Paper16633005
Gender-related differences in outcome for melanoma patients.
Scoggins CR and 15 others. Ann Surg, 2006. Cited by 158 papers, by iCite.
Cite this record
ConductScience Library. Gender-related differences in outcome for melanoma patients. Papers, record 16633005. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/16633005
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Comparative Study, Journal Article, Multicenter Study, Research Support, Non-U.S. Gov't
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Melanoma | Major topic |
| Sentinel Lymph Node Biopsy | Major topic |
| Skin Neoplasms | Major topic |
| Adolescent | |
| Adult | |
| Aged | |
| Female | |
| Humans | |
| Male | |
| Middle Aged | |
| Prospective Studies | |
| Sex Factors | |
| Survival Rate |
Source PubMed
References38
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 2776106 | Tumor thickness and prognosis in clinical stage I malignant melanoma. | Cancer | 1989 | https://conductscience.org/library/papers/2776106 | PubMed |
| 2 | 15221928 | Lessons learned from the Sunbelt Melanoma Trial. | J Surg Oncol | 2004 | https://conductscience.org/library/papers/15221928 | PubMed |
| 3 | 2593166 | Model predicting survival in stage I melanoma based on tumor progression. | J Natl Cancer Inst | 1989 | https://conductscience.org/library/papers/2593166 | PubMed |
| 4 | 10883662 | The effect of tamoxifen and cisplatin on the disease-free and overall survival of patients with high risk malignant melanoma. | Br J Cancer | 2000 | https://conductscience.org/library/papers/10883662 | PubMed |
| 5 | 14508820 | Use of tamoxifen in the treatment of malignant melanoma. | Cancer | 2003 | https://conductscience.org/library/papers/14508820 | PubMed |
| 6 | 8610631 | The addition of tamoxifen to dacarbazine and cisplatin in metastatic malignant melanoma. A phase II trial of the Southwest Oncology Group, (SWOG-8921). | Am J Clin Oncol | 1996 | https://conductscience.org/library/papers/8610631 | PubMed |
| 7 | 15978442 | Predictors of nonsentinel lymph node positivity in patients with a positive sentinel node for melanoma. | J Am Coll Surg | 2005 | https://conductscience.org/library/papers/15978442 | PubMed |
| 8 | 10223239 | A phase III randomized trial of dacarbazine and carboplatin with and without tamoxifen in the treatment of patients with metastatic melanoma. | Cancer | 1999 | https://conductscience.org/library/papers/10223239 | PubMed |
| 9 | 7388745 | The prognostic significance of ulceration of cutaneous melanoma. | Cancer | 1980 | https://conductscience.org/library/papers/7388745 | PubMed |
| 10 | 14993020 | Correlation between prognostic factors and increasing age in melanoma. | Ann Surg Oncol | 2004 | https://conductscience.org/library/papers/14993020 | PubMed |
| 11 | 7370919 | Histologic features of tumors and the female superiority in survival from malignant melanoma. | Cancer | 1980 | https://conductscience.org/library/papers/7370919 | PubMed |
| 12 | 15313732 | Sentinel node biopsy provides more accurate staging than elective lymph node dissection in patients with cutaneous melanoma. | Ann Surg Oncol | 2004 | https://conductscience.org/library/papers/15313732 | PubMed |
| 13 | 11176132 | Sentinel lymph node biopsy in the management of patients with primary cutaneous melanoma: review of a large single-institutional experience with an emphasis on recurrence. | Ann Surg | 2001 | https://conductscience.org/library/papers/11176132 | PubMed |
| 14 | 10791854 | Regional nodal basin control is not compromised by previous sentinel lymph node biopsy in patients with melanoma. | Ann Surg Oncol | 2000 | https://conductscience.org/library/papers/10791854 | PubMed |
| 15 | 11314933 | Sentinel lymph node biopsy for melanoma: how many radioactive nodes should be removed? | Ann Surg Oncol | 2001 | https://conductscience.org/library/papers/11314933 | PubMed |
| 16 | 462379 | A multifactorial analysis of melanoma. II. Prognostic factors in patients with stage I (localized) melanoma. | Surgery | 1979 | https://conductscience.org/library/papers/462379 | PubMed |
| 17 | 7850555 | Age as a prognostic factor in the malignant melanoma population. | Ann Surg Oncol | 1994 | https://conductscience.org/library/papers/7850555 | PubMed |
| 18 | 11490343 | Factors that predict the presence of sentinel lymph node metastasis in patients with melanoma. | Surgery | 2001 | https://conductscience.org/library/papers/11490343 | PubMed |
| 19 | 427730 | Tumor thickness as a guide to surgical management of clinical stage I melanoma patients. | Cancer | 1979 | https://conductscience.org/library/papers/427730 | PubMed |
| 20 | 8167894 | Review and current perspectives of cutaneous malignant melanoma. | J Am Coll Surg | 1994 | https://conductscience.org/library/papers/8167894 | PubMed |
Cited by74
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 158 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41665269 | Impact of Teledermoscopy on Melanoma Diagnosis and Triage Efficiency in Northern Sweden. | Acta Derm Venereol | 2026 | https://conductscience.org/library/papers/41665269 | PubMed |
| 40874540 | Impact of Social Determinants on Melanoma Outcomes in Canada: A Single-Centre Retrospective Study. | J Surg Oncol | 2025 | https://conductscience.org/library/papers/40874540 | PubMed |
| 40839143 | Sex-Based Differences in Medullary Thyroid Cancer Survival: A Matched Analysis of 4602 Patients. | Ann Surg Oncol | 2025 | https://conductscience.org/library/papers/40839143 | PubMed |
| 40536492 | Twenty-year survival outcomes after multipeptide vaccination for resected high-risk melanoma: A post-hoc analysis of a randomized clinical trial. | Int J Cancer | 2025 | https://conductscience.org/library/papers/40536492 | PubMed |
| 40182046 | Alpha-synuclein knockout impairs melanoma development and alters DNA damage repair in the TG3 mouse model in a sex-dependent manner. | Front Oncol | 2025 | https://conductscience.org/library/papers/40182046 | PubMed |
| 39883562 | A comparison of myeloid-derived suppressor cell populations in patients with ulcerated vs non-ulcerated melanoma receiving immune checkpoint blockade. | Melanoma Res | 2025 | https://conductscience.org/library/papers/39883562 | PubMed |
| 39852107 | MOX Nanosensors to Detect Colorectal Cancer Relapses from Patient's Blood at Three Years Follow-Up, and Gender Correlation. | Biosensors (Basel) | 2025 | https://conductscience.org/library/papers/39852107 | PubMed |
| 39837817 | Role of the androgen receptor in melanoma aggressiveness. | Cell Death Dis | 2025 | https://conductscience.org/library/papers/39837817 | PubMed |
| 39624748 | A retrospective single-institute study reveals a vertical gradient of the density of cutaneous melanoma from head to toe. | Skin Health Dis | 2024 | https://conductscience.org/library/papers/39624748 | PubMed |
| 39474070 | Analyzing sex imbalance in EGA and dbGaP biological databases: Recommendations for better practices. | iScience | 2024 | https://conductscience.org/library/papers/39474070 | PubMed |
| 39240165 | Gender and melanoma subtype-based prognostic implications of MUC16 and TTN co-occurrent mutations in melanoma: A retrospective multi-study analysis. | Cancer Med | 2024 | https://conductscience.org/library/papers/39240165 | PubMed |
| 38892441 | A Narrative Review of the Role of Estrogen (Receptors) in Melanoma. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38892441 | PubMed |
| 38863718 | Sex differences in cancer and immunotherapy outcomes: the role of androgen receptor. | Front Immunol | 2024 | https://conductscience.org/library/papers/38863718 | PubMed |
| 38491408 | Integrative multi-omics characterization reveals sex differences in glioblastoma. | Biol Sex Differ | 2024 | https://conductscience.org/library/papers/38491408 | PubMed |
| 37829750 | Demographic and clinical features of cutaneous malignant melanoma patients: A single center cohort study. | North Clin Istanb | 2023 | https://conductscience.org/library/papers/37829750 | PubMed |
| 37371985 | Gender Differences in Oxidative Stress in Relation to Cancer Susceptibility and Survival. | Antioxidants (Basel) | 2023 | https://conductscience.org/library/papers/37371985 | PubMed |
| 36554683 | Impact of the COVID-19 Pandemic on Melanoma Diagnosis: Increased Breslow Thickness in Primary Melanomas-A Single Center Experience. | Int J Environ Res Public Health | 2022 | https://conductscience.org/library/papers/36554683 | PubMed |
| 36286041 | Human Melanoma Cells Differentially Express RNASEL/RNase-L and miR-146a-5p under Sex Hormonal Stimulation. | Curr Issues Mol Biol | 2022 | https://conductscience.org/library/papers/36286041 | PubMed |
| 36065342 | Ulcerated Cutaneous Melanoma: A Review of the Clinical, Histologic, and Molecular Features Associated with a Clinically Aggressive Histologic Phenotype. | Clin Cosmet Investig Dermatol | 2022 | https://conductscience.org/library/papers/36065342 | PubMed |
| 35625961 | Effects of COVID-19 Lockdown on Melanoma Diagnosis in Switzerland: Increased Tumor Thickness in Elderly Females and Shift towards Stage IV Melanoma during Lockdown. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/35625961 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/16633005
GET https://conductscience.org/api/papers/v1/16633005/references?page=2